Categories: USA

Washington State University suggests Cannabis can relieve headache

The researchers from Washington State University suggested that Cannabis could relieve headaches. They published a study in the Journal of Pain that revealed the use of cannabis for headache treatment. They found that the inhale of cannabis reduced the self-reported severity of headaches by 47.3% and migraine severity by 49.6%.

The study was based on the analysis of dig data acquired from the headache and migraine patients, according to Washington State University. The patients were using cannabis in real-time, WSU stated. Carrie Cuttler is the associate professor of psychology at Washington State University and the leading author of this paper in the Journal of pain.

Cuttler said, “We were motivated to do this study because a substantial number of people say they use cannabis for headache and migraine.” The big data was analyzed for the first time in this paper. He added that the topic was addressed by few studies and it was a surprising thing for us. He also said that there was a need for further research in that field due to the chances of placebo effects.

Cuttler said, “I suspect there are some slight overestimates of effectiveness.” The study has opened the gates for the researchers in this field. Further research is needed to take on the difficult work. This study gave some information to the patients and doctors about the use of cannabis for the control of headaches and migraines. THC and CBD are the two active ingredients of cannabis. The study had not found any difference in the effectiveness of these two ingredients.

A study was conducted in the past that revealed the more effectiveness of cannabis over ibuprofen in dealing with the headaches. Nabilone, a synthetic cannabinoid drug, was used in that study. Cuttler said that their study gave motivation to the researchers to study the difficult parts. The doctors and patients will also get more information about the use of cannabis for reducing the severity of headaches.

Jackson Sorbo

Managing editor of the Chicago Morning Star

Recent Posts

FDA Approves Revolution Medicines Pancreatic Cancer Drug

The U.S. Food and Drug Administration has approved Revolution Medicines’ targeted cancer drug Rasonque for certain adults with metastatic pancreatic…

16 hours ago

Chicago History Museum Workers Ratify First Contract

Workers at the Chicago History Museum ratified their first union contract on August 25, 2026, with 96% of union members…

4 days ago

White Sox, Rangers Battle for Playoff Position

The Chicago White Sox and Texas Rangers head into Wednesday’s series finale at Rate Field with both clubs fighting for…

5 days ago

Chicago Business Expo Returns to Malcolm X College

Chicago will hold its final Business Resource Expo of 2026 on Saturday, Aug. 29, at Malcolm X College, bringing entrepreneurs…

1 week ago

Bedard Signs $75M Deal, Backs Patrick Kane Return

Connor Bedard has secured his long-term future with the Chicago Blackhawks, signing a five-year, $75 million contract extension that will…

1 week ago

Chicago House Music Festival Returns for Four-Day Run

The Chicago House Music Festival and Conference will return Aug. 27 through 30, bringing four days of free performances, dance…

1 week ago

This website uses cookies.